File size: 26,126 Bytes
27424ca
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
Term	es	nes	pval	sidak	fdr	geneset_size	leading_edge	leading_edge_size
Glycosaminoglycan degradation	0.9228496388706512	2.7378280277947264	0.0061846407359877	0.9764144793748842	0.6617942144649182	7	P54802,P16278,P06865,P07686,P15586,Q9Y251	6
Degradation pathway of sphingolipids including diseases	0.918176921335358	2.7176812004862665	0.0065741147132276	0.9813866256899212	0.6617942144649182	7	P16278,P06865,P06280,Q99519,P17900	5
Sphingolipid metabolism in senescence	0.7860367113959864	2.6080363208706845	0.0091063291357884	0.9960158022295365	0.6916285996335741	11	P04062,P16278,Q06136,Q96G23,O15269,Q16739,Q13510	7
Sphingolipid pathway	0.7681166841316929	2.517807474379978	0.011808784933323	0.9992344788511798	0.6916285996335741	11	P04062,Q96G23,Q8TCT0,Q9NRX5,O95470,O15269,Q16739,Q13510	8
Sphingolipid metabolism integrated pathway	0.8101585878516483	2.5127246345874705	0.0119802806202984	0.9993106655688672	0.6916285996335741	9	Q96G23,Q8TCT0,O95470,O15269,Q16739,P27544,Q13510	7
Sphingolipid metabolism overview	0.8101585878516483	2.5127246345874705	0.0119802806202984	0.9993106655688672	0.6916285996335741	9	Q96G23,Q8TCT0,O95470,O15269,Q16739,P27544,Q13510	7
1q211 copy number variation syndrome	0.7359136683713818	2.2927086563352597	0.0218647838458403	0.9999984116992904	0.6916285996335741	10	Q9Y624,Q96J84,Q16625	3
Mitochondrial complex iv assembly	0.6839113030010858	2.211205061466438	0.0270216400512941	0.9999999347889108	0.6916285996335741	13	P14406,Q7KZN9,Q15526,Q9Y2R0,P13073	5
Metabolism of spingolipids in er and golgi apparatus	0.8513779527558962	2.056782572530976	0.0397071451874799	0.9999999999764584	0.6916285996335741	5	O95470,Q10472,Q8TCT0,Q16739	4
Calcium regulation in cardiac cells	0.5594672463939526	1.9909049958768896	0.0464913328711149	0.9999999999996748	0.6916285996335741	21	P10644,P54709,P17612,P62942,P16615,P04899,P0DP25,P20020	8
Statin inhibition of cholesterol production	0.7529432768663223	1.97157685524165	0.0486579314789483	0.9999999999999176	0.6916285996335741	7	Q8WTV0,Q07954,P04114,P01130,Q14534	5
Familial hyperlipidemia type 3	0.88356838307641	1.9486147253832744	0.0513414522632305	0.999999999999985	0.6916285996335741	4	Q07954,P98155,P01130	3
Proteoglycan biosynthesis	0.8823911026115598	1.9438521242940396	0.051913285986443	0.9999999999999896	0.6916285996335741	4	Q8TB61,Q9NX62	2
Hippo signaling regulation pathways	0.5742622947644551	1.8850352183498045	0.0594250831327893	1.0	0.6916285996335741	17	P10644,P19022,P17612,P42345,P00533,P08069,P04899	7
Genes controlling nephrogenesis	0.6753140239764424	1.8450522711262227	0.0650299352382175	1.0	0.6916285996335741	9	Q9Y5K6,P05556,Q12948,O94813,Q96J84	5
Complement system in neuronal development and plasticity	0.6285271190288262	1.8349349243814	0.0665153322017713	1.0	0.6916285996335741	12	P15529,P06756,Q5KU26,Q08431	4
Glycerophospholipid biosynthetic pathway	0.7415850803246935	1.8170541231842692	0.0692088264319743	1.0	0.6916285996335741	6	Q9BTU6,O14735	2
Development of ureteric collection system	0.7388664011922723	1.8043912867937328	0.0711699880295513	1.0	0.6916285996335741	6	Q5SZK8,O94813	2
Electron transport chain oxphos system in mitochondria	0.5038438632053917	1.7978697078859232	0.0721976575120817	1.0	0.6916285996335741	50	O14949,P13073,P12235,O75964,P12236,P14406,P05141,O96000,Q9Y6M9,Q7KZN9,P00403,Q9UDW1,O43676,Q15526,P03886,O75438,O95169,P03915	18
Kennedy pathway from sphingolipids	0.7831364829396239	1.7619430999855912	0.0780789115965101	1.0	0.6916285996335741	5	O95470,P35790,Q9UG56,P48651	4
Proximal tubule transport	0.658326133858625	1.7571950399294558	0.0788845704262055	1.0	0.6916285996335741	9	P08195,P04920,P36543,P11166	4
Alzheimers disease and mirna effects	0.3833087008892544	1.7135357707050087	0.086614018414834	1.0	0.6916285996335741	82	P12235,P49721,P12236,P45880,O95197,P16615,Q92542,P60900,Q07954,P21796,Q9Y277,Q9NQC3,P05067,P31751	14
Ferroptosis	0.5179930125711968	1.693192598146867	0.0904188130456642	1.0	0.6916285996335741	22	Q9NZ45,Q96QD8,P02786,P09601,P45880,P08195,P16435,Q9Y277	8
Nonalcoholic fatty liver disease	0.4965094628667714	1.6813972863225664	0.0926857722879215	1.0	0.6916285996335741	47	O14949,O95169,P14406,O96000,Q9Y6M9,P00403,Q9P0J0,Q86Y39,Q9UDW1,O43676,P31751,Q96J02,O75438,P13073	14
Alzheimers disease	0.3835858807736104	1.6566014271427512	0.0976000836388382	1.0	0.6916285996335741	81	P12235,P49721,P12236,P45880,O95197,P16615,Q92542,P60900,Q07954,P21796,Q9Y277,Q9NQC3,P05067,P31751	14
Ebola virus infection in host	0.4966134963692284	1.6523165858379032	0.0984700299248744	1.0	0.6916285996335741	45	P20339,O75569,P61916,O15118,P10321,P06756,P01889,P04439,P05556,Q07021,P00533,Q08431,P51149,P07858,P51151	15
Oxidation by cytochrome p450	0.8091177435224507	1.6435493097303682	0.1002693319178882	1.0	0.6916285996335741	4	P16435,O43169,Q16850	3
Copper homeostasis	0.6599297436731786	1.6405784883398211	0.1008849434303271	1.0	0.6916285996335741	8	P05067	1
Endothelin pathways	0.656411329159041	1.6227570606422237	0.1046413481888117	1.0	0.6916285996335741	8	P16615,P42892	2
Insulin signaling in adipocytes diabetic condition	0.7492928052531338	1.6127360987528714	0.1068018542966657	1.0	0.6916285996335741	5	P14672,P31751	2
Insulin signaling in adipocytes normal condition	0.7492928052531338	1.6127360987528714	0.1068018542966657	1.0	0.6916285996335741	5	P14672,P31751	2
Neural crest cell migration in cancer	0.6517443829891443	1.5990730993446156	0.1098043611090613	1.0	0.6916285996335741	8	Q99523	1
S1p receptor signal transduction	0.6252986821495262	1.5841095954509734	0.1131687811730453	1.0	0.6916285996335741	9	Q9H0H5,P04899,Q13510,P31751	4
Familial hyperlipidemia type 4	0.7898329665405838	1.5633758281032788	0.117964222193414	1.0	0.7097470748214686	4	Q07954	1
Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells	0.6432248177332794	1.555708005918485	0.1197775419701223	1.0	0.7097470748214686	8	P20339,P51148,P61020,P31943	4
P53 transcriptional gene network	0.642119144404633	1.550067999929637	0.1211251956570207	1.0	0.7097470748214686	8	P04066	1
Complement system	0.5659314890753475	1.5307217734671954	0.1258381701586266	1.0	0.7097470748214686	13	P98164,P17612,Q07021,P08754,P15529,P04899,P07942	7
Vitamin b12 metabolism	0.6130989027182362	1.5194538375559516	0.1286482992342308	1.0	0.7097470748214686	9	P04114,P01130,P98164	3
Allograft rejection	0.5874623004181045	1.5043361654764025	0.1324948315288572	1.0	0.7097470748214686	10	P04439,P10321	2
Lipid particles composition	0.938708620124549	1.4981185116764326	0.1341024623229889	1.0	0.7097470748214686	2	P04114	1
Regulatory circuits of the stat3 signaling pathway	0.5851465852376309	1.4915100646507342	0.1358276307743833	1.0	0.7097470748214686	10	P15260,P42345,P00533	3
Camkk2 pathway	0.5848159408305514	1.4896775478452744	0.1363090408597522	1.0	0.7097470748214686	10	P42345,O76024,Q13501,P09601	4
Transcription factors regulate mirnas related to cardiac hypertrophy	0.759425786471756	1.4362101105385046	0.1509425629142229	1.0	0.7397442663362056	4	P31751	1
Overlap between signal transduction pathways contributing to lmna laminopathies	0.5397771116460306	1.4321194607798964	0.1521096358975431	1.0	0.7397442663362056	14	O60725,P42167,P55209,O75844	4
Familial hyperlipidemia type 2	0.8580288061333038	1.4188394548177132	0.1559458270282609	1.0	0.7397442663362056	3	P04114	1
Ccl18 signaling pathway	0.5704241158759769	1.4096393943181116	0.1586461885456527	1.0	0.7397442663362056	10	Q86UE4,P11166,P19022,P00403	4
Small cell lung cancer	0.5257986290956892	1.4093117213315165	0.1587430144046187	1.0	0.7397442663362056	15	P07942,P06756,P31751	3
Metabolic pathway of ldl hdl and tg including diseases	0.7394609198560657	1.3523280642963025	0.1762703904226916	1.0	0.7430209417992328	4	P04114,P01130	2
Immune response to tuberculosis	0.8401551283680877	1.3475341404289558	0.1778082655855253	1.0	0.7430209417992328	3	P15260	1
Head and neck squamous cell carcinoma	0.5134489341173961	1.3300495135735733	0.1835019581336749	1.0	0.7430209417992328	15	P62942,P42345,P00533,P08069,P49815,P31751	6
Familial hyperlipidemia type 1	0.8350904281212077	1.3273288336239877	0.1843999298153491	1.0	0.7430209417992328	3	Q07954	1
Familial hyperlipidemia type 5	0.8350904281212077	1.3273288336239877	0.1843999298153491	1.0	0.7430209417992328	3	Q07954	1
Relationship between inflammation cox2 and egfr	0.6385190287778142	1.3269504674669617	0.184525068327624	1.0	0.7430209417992328	6	P31751	1
Ranklrank signaling pathway	0.4994101881029774	1.3072461676013545	0.1911291204825276	1.0	0.7437856270126948	16	Q13501	1
Cholesterol biosynthesis with skeletal dysplasias	0.6795623532404351	1.3004024335365096	0.1934630763112617	1.0	0.7437856270126948	5	Q15392,Q14739,Q16850	3
Glycerolipids and glycerophospholipids	0.6776826983658406	1.2919166802234037	0.1963860005468354	1.0	0.7437856270126948	5	Q9UG56,P48651,O14735	3
Type ii diabetes mellitus	0.6298203736793333	1.2848060451820502	0.1988600693733997	1.0	0.7437856270126948	6	P14672,Q15526	2
Adipogenesis	0.5045191179785312	1.272466845736696	0.2032072966619686	1.0	0.7437856270126948	15	Q9NZ45,O75844,P43490	3
Autosomal recessive osteopetrosis pathways	0.8209917851830573	1.271106049485221	0.2036909234921256	1.0	0.7437856270126948	3	P51798	1
Familial partial lipodystrophy fpld	0.6073300406491229	1.2611220613437042	0.2072648733080109	1.0	0.7437856270126948	7	O75844,P31751	2
Mitochondrial complex iii assembly	0.5850144703106582	1.2554528406288192	0.2093144175389416	1.0	0.7437856270126948	8	O14949,Q6DKK2,Q9UDW1	3
Extracellular vesiclemediated signaling in recipient cells	0.6035507175631032	1.2421753192066889	0.2141718837247002	1.0	0.7437856270126948	7	Q08431,P00533	2
Network map of sarscov2 signaling pathway	0.4583362302617132	1.2385807448838029	0.2155008025285125	1.0	0.7437856270126948	26	Q08380,O95067,Q07021,P42345,Q96B36,Q96J02,P07858,Q7Z434	8
Orexin receptor pathway	0.4859941894642937	1.2177381948484158	0.2233234776172958	1.0	0.7577942723643073	16	P11166,P01130,P14672	3
Monoamine transport	0.8049180327868792	1.2070922262794723	0.2273966283166006	1.0	0.7630420194623712	3	Q92692,O15127	2
Zinc homeostasis	0.8666011143887418	1.2004142039708166	0.2299785151499094	1.0	0.7674421168538414	2	Q8NEW0	1
Vitamin d metabolism	0.8006894330937309	1.1902751825189506	0.2339382517429451	1.0	0.772124065861961	3	P38435	1
Amyotrophic lateral sclerosis als	0.5289384498535694	1.176297985518618	0.2394758204934088	1.0	0.7796091473946298	10	P07196,P20339,Q9BUN8	3
Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway	0.6973208791845166	1.174791070189934	0.2400783136016575	1.0	0.7796091473946298	4	P09601	1
Nrp1triggered signaling pathways in pancreatic cancer	0.4959642296740347	1.1579859569973974	0.2468697672364028	1.0	0.7875121052336689	14	P31751,P00533	2
Myometrial relaxation and contraction pathways	0.4756285753644302	1.1482853019100034	0.2508508047543074	1.0	0.787815837654049	16	P10644,P16615,P0DP25	3
Mrna protein and metabolite inducation pathway by cyclosporin a	0.7872131147541015	1.1367699650013787	0.2556344622912943	1.0	0.7882397146984421	3	P08195,Q15758	2
Inclusion body myositis	0.7851465342198681	1.1285791732389714	0.259075400488745	1.0	0.7903108176525352	3	P05067	1
Hippomerlin signaling dysregulation	0.4350402297538417	1.0804863097418058	0.2799256799146103	1.0	0.812341361573203	21	P10644,P06756,P19022,P17612,P05556,P00533,P08069	7
Wnt signaling pathway	0.4969924873227971	1.0672949403098135	0.2858386721634638	1.0	0.8146163662634162	12	Q9BTU6,P49815,P42345	3
Nephrotic syndrome	0.4815769540533402	1.0671038361829996	0.2859249497480864	1.0	0.8146163662634162	14	O75844,Q14108,O00592	3
Omega3 omega6 fatty acid synthesis	0.6272965879265022	1.0640167130697709	0.2873211284102055	1.0	0.8147509932383292	5	Q15067,O95864,O95573,O60488	4
Vitamin a and carotenoid metabolism	0.7609574177186791	1.0330777274560137	0.3015675254466354	1.0	0.8393861076947825	3	Q8WTV0	1
Apoptosisrelated network due to altered notch3 in ovarian cancer	0.4556307869512864	1.0137750687805855	0.3106900942233181	1.0	0.8432257133518335	16	Q13501	1
Dopamine metabolism	0.8203867584398705	1.0127966563513948	0.311157298140877	1.0	0.8432257133518335	2	P21964	1
Embryonic stem cell pluripotency pathways	0.483413889967942	0.9860121632536571	0.3241271441882483	1.0	0.8521261494820475	12	P31751,P00533	2
7oxoc and 7betahc pathways	0.5309054057927108	0.9723822212769294	0.3308604332896636	1.0	0.8613780245989519	8	O15118	1
Spinal cord injury	0.4207072167160914	0.9660009530929556	0.3340437041181634	1.0	0.8622324670400457	22	O94813,Q08722,Q9NQC3	3
Hedgehog signaling pathway wp4249	0.6445023201972949	0.9530922895584072	0.3405433124307218	1.0	0.8684453744543471	4	P98164,P17612	2
Photodynamic therapyinduced nfe2l2 nrf2 survival signaling	0.7377049180327601	0.942138889644895	0.3461215361003895	1.0	0.8684453744543471	3	Q14145,P09601	2
Influence of laminopathies on wnt signaling	0.4855246799328952	0.9295403282361092	0.3526091355163947	1.0	0.8701916451364852	10	O60725,O75844,P14672	3
Metapathway biotransformation phase i and ii	0.4149918931635254	0.9288340644136708	0.3529750878450974	1.0	0.8701916451364852	21	P21964,Q16850,O15217,Q7LGA3,Q86UY6	5
Endometrial cancer	0.4635856002098338	0.90702534973203	0.364393392055087	1.0	0.8910672421104153	13	P31751	1
Factors and pathways affecting insulinlike growth factor igf1akt signaling	0.5158133572125382	0.8933749025246317	0.3716564382359735	1.0	0.9051632608650324	8	P08069,P05556,P42345	3
Oxidative phosphorylation	0.4146356933114568	0.8884871296880261	0.3742787758823831	1.0	0.9078890788472266	30	O75787,O75964,O96000,Q9Y6M9,Q15904,Q86Y39,P03886,O75438,P03915	9
Hair follicle development cytodifferentiation part 3 of 3	0.6277043371624207	0.8833133185550849	0.3770670097800228	1.0	0.9097792906823498	4	Q02487,P00533	2
Vasopressinregulated water reabsorption	0.451352975402945	0.8756999956087071	0.3811931477460342	1.0	0.9097792906823498	14	P20339,P51148,P61020,Q13561	4
Purinergic signaling	0.719016393442611	0.869900451697827	0.3843548086015129	1.0	0.9097792906823498	3	P04899,P08754	2
Nucleotidebinding oligomerization domain nod pathway	0.5109779133660078	0.8681057176141896	0.3853364613027308	1.0	0.9097792906823498	8	Q13685	1
Cannabinoid receptor signaling	0.6207393925503735	0.8545503608352751	0.3928001180822651	1.0	0.9118595569725294	4	P10644	1
Type ii interferon signaling ifng	0.5077829158807411	0.8514261716591275	0.3945326585871989	1.0	0.9118595569725294	8	Q03518,P15260	2
Nanomaterial induced apoptosis	0.5354195283284036	0.825761183199195	0.4089395774947046	1.0	0.9199072000468294	6	O95831	1
Angiopoietinlike protein 8 regulatory pathway	0.4003112148078476	0.7802450233622523	0.4352466657380205	1.0	0.9228956332562892	28	O75955,P42345,P14672,Q14254,P11166,P49815,O14654,P31751	8
Neuroinflammation	0.6889889702736267	0.7559870286995404	0.4496569728149744	1.0	0.936526936483602	3	P00403	1
Target of rapamycin tor signaling	0.4508702388887594	0.7329660626285499	0.4635791285605084	1.0	0.9409149444260896	10	P62942,Q9HB90,P49815,P42345	4
Splicing factor nova regulated synaptic proteins	0.4206864855705903	0.7268377303707421	0.4673253667143879	1.0	0.9409149444260896	15	Q9UNS2,P19022,Q06481	3
Vitamin d receptor pathway	0.4273717256649001	0.7243844513195657	0.4688297429019892	1.0	0.9409149444260896	14	P14672,Q96KA5,P48960	3
Insulin signaling	0.3903922228744368	0.7001605715624324	0.4838270318780928	1.0	0.9409149444260896	41	P10586,Q9H4M9,O75955,P42345,P14672,Q14254,P08069,P11166,O14654,P31751	10
Follicle stimulating hormone fsh signaling pathway	0.4948866998953752	0.6973932281010153	0.485556738354038	1.0	0.9409149444260896	7	P17612,P42345	2
Pi3kaktmtor signaling pathway and therapeutic opportunities	0.6670047736970617	0.6747744643745531	0.499819066384298	1.0	0.9499100632703243	3	P42345	1
Gastric cancer network 2	0.41255714903757	0.6743037630662891	0.5001182121191443	1.0	0.9499100632703243	15	Q86UE4,P00533	2
Primary focal segmental glomerulosclerosis fsgs	0.3811708965031605	0.6659832841332403	0.5054217849068812	1.0	0.9515767981985478	22	O00592,P06756,P19022,Q14108	4
Physiological and pathological hypertrophy of the heart	0.5008204791598372	0.6603777479614789	0.5090114482685744	1.0	0.9515767981985478	6	P63000,P61586,P40763,Q9P2K5,Q08209	5
Arrhythmogenic right ventricular cardiomyopathy	0.4163988901350233	0.6556894793212164	0.5120239394280266	1.0	0.9515767981985478	14	P06756,P19022,P16615,P05556,Q14126,P50402	6
Striated muscle contraction pathway	0.5687590181174207	0.644592859437771	0.5191910634556742	1.0	0.9591901713875792	4	P28289,P08670	2
Thyroid hormones production and peripheral downstream signaling effects	0.4029823151051108	0.6128032625980033	0.540006433335245	1.0	0.9745816132184064	15	P06756,P49815,P17612,P42345	4
Micrornas in cardiomyocyte hypertrophy	0.3701353164162613	0.5997689258831905	0.5486602453364609	1.0	0.9745816132184064	20	P08069,Q9P2K5,P42345,P31751	4
Mitochondrial complex i assembly model oxphos system	0.3744673816208842	0.5948121636939542	0.5519690359019647	1.0	0.9745816132184064	25	O96000,Q9Y6M9,Q9P0J0,O43676,P03886,O75438,O95169,P03915	8
Leukocyteintrinsic hippo pathway functions	0.5173884514435773	0.578216298729118	0.5631180961677269	1.0	0.9745816132184064	5	P63000,P51153,Q13043,P27348	4
Synaptic vesicle pathway	0.4020280844731249	0.5665865162205455	0.5709951380529663	1.0	0.9745816132184064	14	Q13277,P12235,Q96CW1,O00429	4
Nrf2 pathway	0.3649342232392136	0.5445324505934248	0.5860751240466306	1.0	0.9778712014479696	22	Q13501,P09601,P14672,P11166,O15217,Q15043	6
Vitamin dsensitive calcium signaling in depression	0.505365859833272	0.5278895834807134	0.5975759749041305	1.0	0.9795110961471052	5	P20020	1
Ectoderm differentiation	0.3559297274620254	0.5049660326626888	0.6135826936086022	1.0	0.9795110961471052	19	P16278,O00592	2
Sarscov2 and covid19 pathway	0.5310146585137632	0.5000457886811278	0.6170428366070861	1.0	0.9795110961471052	4	O14786,Q8WTV0	2
Estrogen signaling pathway	0.4627502461437448	0.484442294558248	0.6280720082938851	1.0	0.9795110961471052	6	P17612,Q02750,P31749,P28482,O14920	5
Malignant pleural mesothelioma	0.3321004077669397	0.469526947671158	0.638693027670822	1.0	0.9795110961471052	67	P06756,P19022,P08195,P05556,Q08722,Q07820,P42345,P00533,P08069,Q02487,O00592,P11166,P31751,P07942,Q14574	15
Regulation of apoptosis by parathyroid hormonerelated protein	0.4589665209846126	0.46746324454812	0.6401684830633649	1.0	0.9795110961471052	6	Q9BXK5	1
Omega9 fatty acid synthesis	0.4509353462422059	0.4318018136138448	0.6658854612826275	1.0	0.9795110961471052	6	O95573,O00767,O95864,P33121,O60488	5
Nanoparticlemediated activation of receptor signaling	0.4248824452452148	0.4309071454308271	0.6665358877042165	1.0	0.9795110961471052	8	P00533	1
Dna damage response only atm dependent	0.3609683825609417	0.4303026208213859	0.6669755208993886	1.0	0.9795110961471052	17	P01130	1
Eicosanoid synthesis	0.6601114388725193	0.428923461857923	0.6679789254484452	1.0	0.9795110961471052	2	P09960	1
Tyrobp causal network in microglia	0.5104248906744155	0.4253082502419359	0.6706119800484138	1.0	0.9795110961471052	4	P61916	1
Folate metabolism	0.3715481087438639	0.4153665728829376	0.6778735731614072	1.0	0.9795110961471052	15	P04114,P01130,Q8WTV0	3
Hepatitis b infection	0.3500264749426656	0.4114750317485565	0.6807242458627387	1.0	0.979885561722635	25	Q15904,Q9Y277	2
Nonsmall cell lung cancer	0.3747695787565608	0.4017482203601388	0.6878693328292029	1.0	0.979885561722635	14	P31751	1
Drug induction of bile acid pathway	0.6506063585709783	0.4001402204063146	0.6890532416985582	1.0	0.979885561722635	2	Q06520	1
Nuclear receptors in lipid metabolism and toxicity	0.6506063585709538	0.4001402204062425	0.6890532416986113	1.0	0.979885561722635	2	P28288	1
Tgfbeta signaling pathway	0.3526001031469378	0.3886091568297575	0.6975652920302775	1.0	0.9890362356485624	33	Q96J02,P05556,P05067,Q96PU5	4
Complement and coagulation cascades	0.5766120770818973	0.3713916788335088	0.7103458224366339	1.0	0.992054765907683	3	P15529	1
H19 action rbe2f1 signaling and cdkbetacatenin activity	0.4359234183571067	0.3666808041340195	0.7138571267818459	1.0	0.992054765907683	6	Q16527	1
Notch signaling pathway	0.3799045277419427	0.3608554738836996	0.7182074906272369	1.0	0.992054765907683	11	Q92542	1
Arachidonate epoxygenase epoxide hydrolase	0.6368403802032219	0.3601220350532738	0.7187558751675762	1.0	0.992054765907683	2	P34913	1
Glycosylation and related congenital defects	0.3818707753348827	0.3562914876598813	0.721622283483047	1.0	0.9928470597352174	10	Q9BV10,Q9BT22,Q9Y5P6,Q2TAA5,Q9H0U3	5
Neuroinflammation and glutamatergic signaling	0.3369726102519064	0.3244471348885355	0.7455995395115056	1.0	1.0	24	P09622,P15260,P11166	3
T cell receptor and costimulatory signaling	0.4804854050508339	0.3233576313339398	0.7464244126831407	1.0	1.0	4	P49840,Q08209,P48729	3
Progeriaassociated lipodystrophy	0.3857386617413525	0.3085895559697726	0.7576337665040913	1.0	1.0	9	O75844	1
Triacylglyceride synthesis	0.5544262295081933	0.3073925559349643	0.7585445935994215	1.0	1.0	3	O00116,Q99943	2
Hair follicle development organogenesis part 2 of 3	0.5499303727562399	0.2950535298314504	0.7679529879973175	1.0	1.0	3	P05556	1
Focal adhesion pi3kaktmtorsignaling pathway	0.3402265320533773	0.2783080809453814	0.7807758733778933	1.0	1.0	41	P06756,P05556,P14672,P42345,P08069,P00533,P11166,P61019,O14654,P07942,P31751	11
Caloric restriction and aging	0.4402050504237926	0.2756438521609506	0.7828216247892004	1.0	1.0	5	P43490	1
Selenium micronutrient network	0.3604127596214891	0.2744908835278578	0.7837074085717128	1.0	1.0	12	P04114,P01130	2
G protein signaling pathways	0.346489942589683	0.2658576609305184	0.7903488336004645	1.0	1.0	15	P10644,P04899,P17612,P08754	4
Pi3kakt signaling pathway	0.338646738182492	0.265666583053352	0.7904960016270492	1.0	1.0	40	P06756,P05556,Q07820,P42345,P00533,P08069,P07942,P31751	8
Sulfation biotransformation reaction	0.4621187274516081	0.2655092591998454	0.790617177939952	1.0	1.0	4	Q06520,P00390,P11413	3
Ras signaling	0.3356515051886627	0.2635974037033215	0.7920901593364986	1.0	1.0	32	P20339,P17612,P61020,P00533,P0DP25,P51148,P11233,P31751	8
Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition	0.4220266811588908	0.21360837043069	0.8308524713969312	1.0	1.0	5	P19022	1
Mammary gland development pathway pregnancy and lactation stage 3 of 4	0.3920572609366161	0.1911391877703267	0.8484165461835507	1.0	1.0	6	P18031,P00533	2
Phase i biotransformations non p450	0.5039836342390711	0.1824655555033809	0.855217383291438	1.0	1.0	3	P38571	1
Autophagy	0.3883426927235624	0.1775045647369254	0.8591120800266032	1.0	1.0	6	P42345,Q9Y4P8	2
Map3k1 role in promoting and blocking gonadal determination	0.5003278688524566	0.1746295349442683	0.861370739643488	1.0	1.0	3	P35222,P61586	2
Glycogen synthesis and degradation	0.3232527708745475	0.1616602736206255	0.8715733900133025	1.0	1.0	16	P52789,P0DP25	2
Cardiac hypertrophic response	0.3338630177754303	0.1407788615571635	0.8880446427719018	1.0	1.0	12	P31751	1
Mirna regulation of prostate cancer signaling pathways	0.3686802363755685	0.1355441959384514	0.8921816233447202	1.0	1.0	7	P35222,Q02750,P42345,Q8NCF5,P28482,P62993	6
Angiogenesis	0.4803278688524663	0.1348437103130983	0.8927354455852654	1.0	1.0	3	Q05397,P28482	2
Initiation of transcription and translation elongation at the hiv1 ltr	0.3683519369665131	0.1343411460484151	0.8931328182719942	1.0	1.0	7	Q92769,Q08209,P50750,Q13547,P18615,Q8IXH7	6
Thyroid stimulating hormone tsh signaling pathway	0.3060955518945714	0.1248276633623664	0.9006599864806861	1.0	1.0	18	P62753,P11802,Q14344,P27695,P40763,Q14160,Q15418,Q02750,P42345,P08754,P08069,P42224,P04899,P31749,P28482,P24941,P63096	17
Hippoyap signaling pathway	0.5260570304817999	0.122035489177529	0.9028709120124736	1.0	1.0	2	Q13043	1
Bdnftrkb signaling	0.3537116560683669	0.1183131700746827	0.9058195224829004	1.0	1.0	8	P42345	1
Wnt signaling in kidney disease	0.5168797115699667	0.1094538115893897	0.912842554604662	1.0	1.0	2	P35222	1
Serotonin htr1 group and fos pathway	0.3603403680253864	0.1055933482257589	0.91590500259235	1.0	1.0	7	P04899,P08754	2
Mapk and nfkb signaling pathways inhibited by yersinia yopj	0.4622950819672204	0.1034979773258335	0.917567754735088	1.0	1.0	3	O14920,P28482	2
Vitamin d in inflammatory diseases	0.4622950819672203	0.1034979773258332	0.9175677547350882	1.0	1.0	3	O14920,Q08209	2
Thymic stromal lymphopoietin tslp signaling pathway	0.3271550220465017	0.1007036580582285	0.9197857074285424	1.0	1.0	11	Q9BTU6	1
Neural crest differentiation	0.3634301704396601	0.0920639772790255	0.926647208831596	1.0	1.0	6	P19022	1
Somatroph axis gh and its relationship to dietary restriction and aging	0.3875910970595399	0.0770164072738196	0.9386104926180108	1.0	1.0	4	P42345	1
Regucalcin in proximal tubule epithelial kidney cells	0.3516086671043944	0.0756499017497625	0.9396976343236628	1.0	1.0	7	P42574,Q13283,P42345,Q8NE86,P31749,P28482	6
Praderwilli and angelman syndrome	0.3684383202099724	0.0598425330392189	0.952281049791166	1.0	1.0	5	P11802,Q15154,Q7L576,O95714	4
Pregnane x receptor pathway	0.366797900262464	0.05590463609752	0.9554177775363206	1.0	1.0	5	Q06520,P08183,P62195,Q99615	4
Nodlike receptor nlr signaling pathway	0.4621435594886796	0.0551254541135315	0.95603851752279	1.0	1.0	2	O14920	1
Altered glycosylation of muc1 in tumor microenvironment	0.4621435594886796	0.0551254541135315	0.95603851752279	1.0	1.0	2	O14920	1
Ovarian infertility	0.4575549000327634	0.0520109626759746	0.9585199582859096	1.0	1.0	2	P11802	1
Liver x receptor pathway	0.4503441494591832	0.0475044159180791	0.9621112109173172	1.0	1.0	2	O00767	1
Nocgmppkg mediated neuroprotection	0.3664252200282965	0.0388114703040504	0.969040699745692	1.0	1.0	4	P07196,Q13555	2
Benzoapyrene metabolism	0.333988856112743	0.0181993136692253	0.9854798501591562	1.0	1.0	2	P07099	1
Hostpathogen interaction of human coronaviruses apoptosis	0.3512627090849463	0.0157501522713423	0.9874337162218904	1.0	1.0	4	Q07820,P31749,P42574	3
Brainderived neurotrophic factor bdnf signaling pathway	0.3058204790543557	0.0120489925198822	0.9903865275068582	1.0	1.0	42	Q13501,Q99523,Q96P70	3
Srebf and mir33 in cholesterol and lipid homeostasis	0.3318439627028109	0.0006495234232512	0.9994817553251476	1.0	1.0	6	P01130	1